NEW YORK, Oct. 14, 2013 /PRNewswire-iReach/ -- NEW YORK, NEW YORK – (October 14, 2013) – Reproductive Medicine Associates of New York, a Manhattan-based infertility clinic, will be presenting 20 abstracts at this year's ASRM (American Society for Reproductive Medicine) annual meeting taking place in Boston, Massachusetts starting October 12th through the 17th.
Among the research to be presented are new discoveries in the identification of biomarkers for female fertility, discoveries involving the motivations of female patients choosing to undergo elective oocyte cryopreservation and the consumption of alcohol and its potential relationship to infertility.
Whole Genome Sequencing for Female Infertility Biomarker Discovery will be presented as a poster [P013] as a part of the Female Reproductive Endocrinology session on Wednesday, October 16th from 7:00 AM to 8:45 AM. The study, conducted in partnership with Celmatix, Inc., by Dr. Piraye Yurttas Beim et al., examines the discovery of important prognostic biomarkers that could potentially be a powerful diagnostic tool in the treatment of infertility.
What Makes A Woman Freeze: The Impetus Behind Patients' Desires To Undergo Elective Oocyte Cryopreservation will be an oral presentation by Dr. Georgia Witkin, Ph.D., Clinical Psychologist at RMA of New York and Assistant Professor in the Department of Reproductive Science and in the Department of Psychiatry at Mount Sinai Medical Center. The presentation, by Dr. Georgia Witkin et al., will take place as a part of the Mental Health session on Monday, October 14th from 4:00 PM to 4:15 PM.
Assisted Reproductive Registered Dietitian Assessment: Does Prior Alcohol Intake Affect A Woman's Cycle Outcome? will be presented as a poster [P-953] as a part of the Nutrition session on Thursday, October 17th. The study, by Dara Godfrey, MS RD, et al., will examine the effect of alcohol intake on the cycles of women undergoing infertility treatment.
In addition to these events a number of other presentations will take place over the course of the annual meeting in Boston.
Same Sex Female Couples Undergoing IVF With Their Partner's Eggs (Co-IVF): Pathways to Parenthood by Joseph Lee, B.A., et al., will be presented as an oral [O-222] on Tuesday, October 15th from 4:00 PM to 6:00 PM.
Accurate Prediction Of The Number Of Cycles To Achieve Live Birth by Michael Elashoff, Ph.D., et al., in association with Celmatix, Inc., will be given as an oral presentation [O-460] as a part of the Assisted Reproductive Technologies session on Wednesday, October 16th from 4:45 PM to 5:00 PM.
The fifteen other posters and oral presentations will cover a range of topics in the field of reproductive medicine.
About Reproductive Medicine Associates of New York
Reproductive Medicine Associates of New York (RMA of New York) is widely recognized as a national and international leader in state-of-the-art reproductive medicine. Led by an integrated team of doctors and scientists with extensive reproductive endocrinology, fertility and urology experience and training, RMA of New York consistently reports IVF success rates to the Society for Assisted Reproductive Technology (SART) and the Center for Disease Control and Prevention (CDC) and is internationally recognized for achieving high success rates in the treatment of infertility. RMA of New York maximizes access to care by helping patients explore all insurance coverage and financing options available for treatment. RMA of New York is sensitive to the needs of the LGBT community, women choosing single or same-sex motherhood, as well as women interested in elective fertility preservation. Headquartered in midtown Manhattan, RMA of New York has patient care facilities in Garden City, White Plains, Brooklyn and Cornwall, NY. For more information, please visit www.rmany.com.
Media Contact: Victoria Andretta, Reproductive Medicine Associates of New York, 212-756-5777, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Reproductive Medicine Associates of New York